The role of biomarkers is increasingly recognized in heart failure (HF) management, for diagnosis, prognostication, and screening of high-risk patients. Beyond natriuretic peptides and troponins, the utility of novel, emerging biomarkers is less established. This document reflects the key points of a Heart Failure Association of the European Society of Cardiology (ESC) consensus meeting on biomarker monitoring in HF.

Spoletini, I., Coats, A., Senni, M., & Rosano, G. (2019). Monitoring of biomarkers in heart failure. EUROPEAN HEART JOURNAL SUPPLEMENTS, 21, 5-8 [10.1093/eurheartj/suz215].

Monitoring of biomarkers in heart failure

Senni M;
2019

Abstract

The role of biomarkers is increasingly recognized in heart failure (HF) management, for diagnosis, prognostication, and screening of high-risk patients. Beyond natriuretic peptides and troponins, the utility of novel, emerging biomarkers is less established. This document reflects the key points of a Heart Failure Association of the European Society of Cardiology (ESC) consensus meeting on biomarker monitoring in HF.
Articolo in rivista - Articolo scientifico
Scientifica
Biomarkers; Heart failure; Monitoring;
English
Spoletini, I., Coats, A., Senni, M., & Rosano, G. (2019). Monitoring of biomarkers in heart failure. EUROPEAN HEART JOURNAL SUPPLEMENTS, 21, 5-8 [10.1093/eurheartj/suz215].
Spoletini, I; Coats, A; Senni, M; Rosano, G
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10281/372720
Citazioni
  • Scopus 15
  • ???jsp.display-item.citation.isi??? 14
Social impact